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Background-—Improvements in hospital-based care have reduced early mortality in congenital heart disease. Later adverse
outcomes may be reducible by focusing on care at or after discharge. We aimed to identify risk factors for such events within 1
year of discharge after intervention in infancy and, separately, to identify subgroups that might beneﬁt from different forms of
intervention.
Methods and Results-—Cardiac procedures performed in infants between 2005 and 2010 in England and Wales from the UK
National Congenital Heart Disease Audit were linked to intensive care records. Among 7976 infants, 333 (4.2%) died before
discharge. Of 7643 infants discharged alive, 246 (3.2%) died outside the hospital or after an unplanned readmission to intensive
care (risk factors were age, weight-for-age, cardiac procedure, cardiac diagnosis, congenital anomaly, preprocedural clinical
deterioration, prematurity, ethnicity, and duration of initial admission; c-statistic 0.78 [0.75–0.82]). Of the 7643, 514 (6.7%) died
outside the hospital or had an unplanned intensive care readmission (same risk factors but with neurodevelopmental condition and
acquired cardiac diagnosis and without preprocedural deterioration; c-statistic 0.78 [0.75–0.80]). Classiﬁcation and regression tree
analysis were used to identify 6 subgroups stratiﬁed by the level (3–24%) and nature of risk for death outside the hospital or
unplanned intensive care readmission based on neurodevelopmental condition, cardiac diagnosis, congenital anomaly, and duration
of initial admission. An additional 115 patients died after planned intensive care admission (typically following elective surgery).
Conclusions-—Adverse outcomes in the year after discharge are of similar magnitude to in-hospital mortality, warrant service
improvements, and are not conﬁned to diagnostic groups currently targeted with enhanced monitoring. ( J Am Heart Assoc.
2016;5:e003369 doi: 10.1161/JAHA.116.003369)
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T he main focus in the audit of pediatric cardiac surgery hasbeen operative mortality, expressed as either 30-day
mortality1 or mortality at hospital discharge.2 These very early
outcomes have improved signiﬁcantly over time,3,4 but while
relevant to quality assurance, they cannot inform service
improvements outside the hospital setting. There remains a
signiﬁcant risk of death or clinical deterioration following
discharge after “successful” surgery. For instance, “interstage
mortality” for infants with hypoplastic left heart syndrome
(HLHS) was 12% within a recent multicenter trial.5 Single-
center reports indicate that home monitoring programs of
enhanced postdischarge surveillance for HLHS reduce inter-
stage mortality,6–9 but this practice is not universally imple-
mented5 and local protocols vary.10 Studies of postdischarge
outcomes for congenital heart disease (CHD) other than HLHS
are sparse,11 and a greater understanding of the risk of adverse
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outcomes after discharge among the broader patient popula-
tion could usefully inform quality improvement efforts.
To this end, we undertook a national study of outcomes in
the ﬁrst year after discharge from hospital among infants
undergoing intervention for CHD. Our ﬁrst aim was to
measure the rates of adverse outcomes at 1 year among
this population and then identify patient-level factors inde-
pendently associated with these outcomes. Our second,
complementary aim was to identify groups of patients who
might beneﬁt from different interventions because of the
differing nature and scale of risk that they face. The adverse
events of interest to us were deaths in the community and any
unplanned readmissions to intensive care, regardless of
outcome, in the ﬁrst year after discharge, because these
are potentially avoidable through improved care at or after
discharge. Deaths in the ﬁrst year postdischarge that
occurred after a planned readmission to intensive care
(typically for elective surgery as part of a prospectively
planned, staged treatment pathway) were not a focus of this
work because they are less likely to be remediable through
improvements to care at or after discharge.
This national study was possible because of the United
Kingdom’s unique combination of mandatory national audit
data sets for pediatric cardiac procedures (the National
Congenital Heart Disease Audit [NCHDA]12) and pediatric
intensive care unit (PICU) admissions (the Paediatric Intensive
Care Audit Network [PICANet]13), which is augmented in
England and Wales with independently ascertained life status
tracking.
Methods
Ethics
Approval was obtained from the London Central Research
Ethics Committee (reference No. 12/LO/1398) and the
National Health Service (NHS) Health Research Authority
Conﬁdentiality Advisory Group (reference No. ECC 6-02
(FT5)/2012). Requirement for consent was waived.
Constructing the Data Set for Analyses
Data sources and patient population
Two national audit data sets were used: NCHDA12 and
PICANet.13 Data submission to each audit is mandatory,
subject to external data validation,14,15 and each audit has
approval from the relevant regulatory authorities for use of
patient identiﬁable data. The survival status of patients in
NCHDA is independently veriﬁed for patients of English and
Welsh centers by the UK Health and Social Care Information
Centre by using their patients’ unique identiﬁer (NHS number).
All children who underwent their ﬁrst interventional
catheterization or cardiac surgery when younger than 1 year
in the United Kingdom between January 1, 2005 and
December 31, 2010 were identiﬁed in NCHDA (overseas
patients without an NHS number were removed at this stage;
patients treated in Northern Ireland and Scotland were later
identiﬁed and excluded). Records within PICANet for these
patients were then identiﬁed by a trusted third party using
patient NHS number, and patients with record(s) in NHCDA
but not in PICANet were removed and analyzed separately.
Separate data extracts from each audit were provided to the
study team, each with the same patient-level identiﬁer
(pseudonymized NHS number). A single patient potentially
had multiple procedure-based records in the NCHDA extract
and multiple admission-based records in the PICANet extract.
The study team constructed a single patient-based analysis
data set by linking events for the same patient using the
patient-level identiﬁer, including cardiac-related details and
life status (NCHDA) and rich comorbidity and emergency PICU
admission information (PICANet).
Deﬁning the index admission and index procedure
The index admission for each child was deﬁned as the
continuous period as an inpatient within the pediatric cardiac
center, including admission(s) to PICU, that included their ﬁrst
surgical procedure or their ﬁrst deﬁnitive or initial staging
interventional catheter procedure (see Data S1 for included
catheterizations). This period deﬁned the index length of stay
(LOS). Within the NCHDA data set, each procedure is
described based on up to 8 individual procedural International
Paediatric and Congenital Cardiac Codes (IPCCCs).16 An
algorithm developed by the NCHDA Steering Committee
deﬁnes the speciﬁc procedure undertaken, based on the
combinations of IPCCCs recorded. These deﬁned “speciﬁc
procedures” are listed in hierarchical order with the Norwood
operation at the top and, for surgery, ligation of patent ductus
arteriosus (PDA) at the bottom, with interventional catheter
procedures appearing below surgeries in the hierarchy (see
Data S1 for further details). For children who underwent >1
procedure during their index admission, their index interven-
tion was chosen to be the most complex according to this
hierarchy.
Exclusions
Children who underwent only catheter procedure(s) listed as
exclusions in Data S1, premature babies who had ligation of
PDA only, and cardiac transplant patients were excluded from
our analysis because they have their own discharge and
follow-up care pathways. Patients treated in Northern Ireland
and Scotland were also removed because they do not have
veriﬁed life status.
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Candidate Patient Risk Factors
Candidate nonmedical, preoperative and postoperative risk
factors available in the patient-based analysis data set that
would be known at the point of discharge were identiﬁed: these
are provided in Table 1 (with further details regarding the
deﬁnitions in Data S1 and Tables S1–S4). Each child’s primary
cardiac diagnosis was identiﬁed based on a hierarchical IPCCC
coding map,21 which also identiﬁed records where there was a
concurrent acquired cardiac diagnosis. Other clinical informa-
tion, including the presence of comorbid conditions and
postoperative complications, was based on a mapping of Read
codes.22 Where both audits contained information on a
particular risk factor, the most complete source was used.
Clinical variables with multiple parameters were necessarily
collapsed into broad groups before statistical analyses to
reduce the degrees of freedom and, hence, the risk of
overﬁtting.23 Table 2 lists the diagnostic categories within
each of the 4 primary cardiac groups used in the analyses.
Missing data
Where ethnic group was not available from PICANet, the
NCHDA ethnic code was used to assign White, Asian, or Black
Table 1. Candidate Patient Risk Factors
Candidate Factors Categories (or Examples)
Nonmedical factors
Deprivation English index of multiple deprivation17
Ethnicity White, Mixed, Asian, Black, Chinese, “Other”, not stated18,19
Preprocedural risk factors
Primary cardiac diagnosis group Hypoplastic left heart syndrome (HLHS), functionally univentricular heart (UVH) or pulmonary atresia
with intact ventricular septum (PA+IVS), isolated ventricular septal defect (VSD) (a recognizable
biventricular comparator group), “other” (all remaining primary diagnoses consisting of a broad
range of biventricular conditions)
Presence of an acquired cardiac diagnosis For example, acquired atrioventricular block, cardiomyopathy, myocardial ischemia, endocardial
fibroelastosis
Index procedure group Initial staged, definitive repair, “ungrouped”
Presence of a congenital anomaly For example, Downs syndrome, DiGeorge syndrome (22q11 deletion), urogenital/renal malformations,
tracheal/tracheaoesophageal malformations, vision/hearing deficits and exomphalos/gastrointestinal
malformations
Presence of a neurodevelopmental condition For example, epilepsy/seizures, developmental delay, sleep apnea, hydrocephalus, retinopathy of
prematurity, stroke, hemiparesis/hemiplegia, anoxic encephalopathy, cerebral venous sinus
thrombosis and cerebral palsy
Prematurity <37 completed weeks’ gestation
Sex Male, female
Age at procedure Age at index procedure
Weight-for-age at procedure Calculated using World Health Organization reference standards20
Antenatal diagnosis Antenatal diagnosis of congenital heart defect
Clinical deterioration prior to index intervention Emergency admission to intensive care involving retrieval by specialist team
Postprocedural risk factors
Index admission length of stay Continuous period as an inpatient within a specialist paediatric cardiac hospital or PICU that
surrounds a child’s first interventional cardiac procedure in infancy
Receipt of renal support or extracorporeal life
support during index admission
Including dialysis and hemofiltration
Any adverse PICU events during index admission For example, collapse or cardiac arrest, acquired injury or complications, a noncardiac operation
Postprocedural morbidity during index admission For example, postprocedural pneumothorax, mediastinitis, chylothorax, cardiac arrest after procedure
Acquired comorbidities during index admission For example, meconium aspiration syndrome, gastritis, liver failure, pneumonia, Clostridium difficile
infection
Any catheter or surgical procedures performed in
addition to index procedure
Either before or after the index procedure and within the index admission
The candidate nonmedical, preoperative, and postoperative risk factors used in the analyses. These were all available in the patient-based analysis data set and would be known at the
point of discharge. See Data S1 and Tables S1–S4 for further details. PICU indicates pediatric intensive care unit.
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ethnicity (which showed strong concordance across the 2
audits); sensitivity analyses were performed excluding records
without PICANet-derived ethnicity. Weight-for-age outside the
range 5 z-scores was assumed to be erroneous and treated
as missing.
Outcomes
For the majority of our analyses, an adverse event was deﬁned
as either death outside a PICU admission (ie, “in the
community”) or any emergency unplanned readmission to
PICU, regardless of outcome, within 1 year after discharge
from the index admission. We note the inclusion of nonfatal
unplanned readmissions to PICU as these were considered
“near misses” of relevance to informing service improvement.
However, for the purposes of comparison with in-hospital
mortality rates and risk modeling, some analyses were
restricted to fatal adverse events only (deaths outside a
planned admission)—where this was the case, we state this
clearly in the text. Note that this research was designed to
inform improvements in services at discharge and in the
community; therefore, we did not consider death within 1 year
of discharge from the index admission that occurred during a
planned readmission to intensive care (typically for elective
surgery as part of a staged treatment pathway) as an adverse
outcome. Such patients were important to include in the
analysis, however, as the period before the second elective
surgery in a staged treatment pathway is known to be
particularly high risk for many patients.5 Age at death (if
applicable) and life status were available in NCHDA, while
emergency unplanned admissions to PICU were extracted
from PICANet.
Statistical Methods
Descriptive and univariate analyses
Descriptive analyses were performed to characterize the data
set, and univariate logistic regression analysis on complete
case data was used to assess the relation of each candidate
predictor with each outcome by using fractional polynomials
to investigate departure from linearity. This informed which
variables were considered in two additional, complementary
strands of analysis: ﬁrst, the development of a risk model for
adverse event and, separately, for fatal adverse events only,
to generate generalizable knowledge about the individual
underlying risk factors; and second, the identiﬁcation of
patient groups differentiated by risk of adverse event to
inform potential interventions that might beneﬁt certain
subgroups of the population.
Developing risk models for adverse events and for fatal
adverse events only
The signiﬁcant variables from the univariate analysis (P<0.10)
were investigated in a multivariable model for each outcome
in turn. Initially, models were developed in which the
continuous predictors were used and, where appropriate,
suitable transformations were included. For the ﬁnal model
presentation, continuous predictors were categorized based
on considerations of model interpretability as well as
statistical performance.
Multiple imputation (assuming data were missing at
random) was used to account for missing data when ﬁtting
the multivariable models. The imputation models included all
risk factors considered in the univariate analysis (which we
assume includes all predictors of missingness). We generated
Table 2. Primary Cardiac Diagnosis Categories
Cardiac Diagnosis Group Primary Cardiac Diagnosis Category
Hypoplastic left heart syndrome (HLHS) HLHS
Functionally univentricular heart (UVH) or
pulmonary atresia (PA) with an intact
ventricular septum (IVS)
UVH; PA+IVS
Isolated ventricular septal defect (VSD) Isolated VSDinteratrial communication (atrioventricular septal defect [ASD])patent ductus arteriosus (PDA)
Other Common arterial trunk (truncus arteriosus); transposition of the great arteries (TGA)+VSD/double outlet right
ventricle (DORV)-TGA type; interrupted aortic arch; TGA (concordant atrioventricular and discordant
ventriculoatrial connections) and intact ventricular septum; PA+VSD (including Fallot type); miscellaneous
congenital primary diagnoses; ASD; Fallot/DORV-Fallot type; aortic valve stenosis (isolated); tricuspid valve
abnormality (including Ebstein); mitral valve abnormality (including supravalvar, subvalvar); totally
anomalous pulmonary venous connection; aortic arch obstructionVSD/ASD; pulmonary stenosis; subaortic
stenosis (isolated); aortic regurgitation; interatrial communication (ASD); PDA; acquired noncongenital heart
disease; arrhythmia; miscellaneous congenital terms; noncardiac or uncoded diagnosis
The 4 primary cardiac diagnosis groups used in the analyses, which aggregate a set of 26 primary cardiac diagnosis categories, thereby reducing the degrees of freedom and, hence, the
risk of overﬁtting.23 The primary cardiac diagnosis categories themselves are based on a hierarchical IPCCC coding map21 (see Table S2).
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20 data sets and ran a full logistic regression, using the whole
data set and implementing a bootstrap (200 samples) for
each imputed data set to correct for overﬁtting. Signiﬁcant
predictors were selected based on the inclusion frequency
of each predictor over the imputed data sets (ie, the
proportion of times that the factor appeared in the model24;
see Data S2 for further details). The ﬁnal models were
derived by ﬁtting a logistic regression model for all
signiﬁcant predictors, and estimates were combined by
using Rubin rules.25 Model performance was assessed in
terms of discrimination and calibration. The c-statistic (area
under the receiver operator curve), corrected for overﬁtting
by using the bootstrap, was used to summarize the
discrimination of the models.26 The Hosmer–Lemeshow
statistic was used to test calibration (goodness-of-ﬁt), and
the range of P-values obtained over the 20 imputed data
sets is presented.
Sensitivity of the results to adjustment for clustering at
both the hospital level and the regional level (English Primary
Care Trusts27) was assessed for each model by using the
complete case data. All analyses were performed in Stata
13,28 and a value of P<0.05 was considered statistically
signiﬁcant unless otherwise stated.
Identifying patient groups differentiated by risk of
adverse event
Classiﬁcation and regression tree (CART) analysis was used
to identify patient groups with different “proﬁles of risk”
that could usefully inform the development of interventions
targeted at different groups. For other examples of CART
applications in health care, see references 29–31. The
CART algorithm recursively partitioned the data into subsets
that were as homogeneous as possible with respect to
adverse event (ie, into subsets of increasing “purity”).32 All
variables signiﬁcantly associated with adverse event in
univariate analysis were included in the CART analysis, with
continuous variables entered in their categorized form as
per ﬁnal risk model development. To prevent overﬁtting, the
CART groups were developed in a random 60% of the data
and, for reasons of statistical robustness and potential
usability, we restricted the tree depth to 4 and required a
minimum of 100 cases for branching to continue, with at
least 50 cases in either branch. The resulting classiﬁcation
tree was applied to the remaining 40% of the data set and
the occurrence of adverse events among patients at each
node was compared with the corresponding group in the
development set to assess model stability. For both data
sets, the c-statistic was calculated by assessing the ﬁnal
group characterizations obtained in the derivation data set
as a predictor for adverse event. All analysis was performed
in SPSS 22.33
Results
Data Set
A total of 12 390 infants meeting the inclusion criteria and
with a valid patient identiﬁer were identiﬁed in NCHDA, of
whom 9385 (76%) were linked to ≥1 record in PICANet. Of
these, 115 children who had an excluded catheter procedure
only, 765 premature babies who had ligation of PDA only, 24
cardiac transplant patients, and 505 patients from Scotland
or Northern Ireland were removed. Of 3005 patients who
had no linked PICANet record, 1225 would not have been
included in our study as they were either from Scotland or
Northern Ireland or were premature and undergoing a PDA
procedure only. The remaining 1780 demonstrated a greater
prevalence of minor forms of CHD than did patients in the
study data set.
Of the 7976 patients included in our study, 333 (4.2%) died
during their index admission and were excluded from our
analyses, leaving a ﬁnal analysis data set of 7643 infants who
were discharged alive from their index admission. Of these,
246 (3.2%) died within 1 year after discharge from the index
admission and not during a planned admission (fatal adverse
events), and 514 (6.7%) either died or had an emergency
unplanned readmission to PICU within 1 year (all adverse
events). Finally, 115 (1.5%) children died during a planned
admission to PICU within 1 year after discharge from the
index admission (not considered an outcome in our analysis),
giving an overall mortality within the year after discharge from
index admission of 4.7%.
Descriptive and Univariate Analyses
A summary of the descriptive and univariate logistic regres-
sion analyses is presented in the Data S2. There was no
association identiﬁed with either outcome (fatal adverse
events or all adverse events) and with either sex or the
performance of additional cardiac catheterizations during the
index procedure.
Developing Risk Models for Adverse Events and
for Fatal Adverse Events Only
In the multivariable analysis in which continuous variables
were treated as such, the signiﬁcant risk factors for both
outcomes were age at procedure, weight-for-age z-score,
index procedure group, cardiac diagnosis group, noncardiac
congenital anomaly, prematurity, ethnicity, and LOS in a
specialist center. Preprocedural clinical deterioration was
additionally signiﬁcant to fatal adverse events only, while
neurodevelopmental condition and acquired cardiac diag-
noses were additionally signiﬁcant to all adverse events.
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Details of these continuous regression models are presented
in the Data S2. In the ﬁnal model development, the
continuous predictors were categorized as follows: age
at index procedure (>3 months old, 1–2 months old,
10–30 days, 0–10 days old); weight-for-age z-score (>2
SDs, 2 to 4 SDs, <4 SDs); and length of stay (0–7 days,
7–30 days, >1 month). Details of the ﬁnal regression models
for fatal adverse events and all adverse events are shown in
Tables 3 and 4. For all models, adjusting for clustering at
either the hospital or regional level had no statistically
signiﬁcant impact on results when comparing models using
Akaike criteria (we present the unadjusted results).
The c-statistic of the ﬁnal (categorical) model for fatal
adverse events was 0.78 (95% CI 0.75–0.82), indicating
good discrimination (and only marginally less discriminative
than the continuous model, c-statistic 0.80). The ﬁnal
(categorical) model for all adverse events also showed good
discrimination with a combined c-statistic of 0.78 (0.75–
0.80) compared with 0.78 for the continuous model.
Calibration of the ﬁnal categorical and continuous models
for both outcomes was also good, with Hosmer–Lemeshow
P-values ranging from 0.10 to 0.75 across the models ﬁtted
on the 20 imputed data sets, indicating no statistically
signiﬁcant differences between observed and expected
number of deaths when calculated in deciles of predicted
risk for each of the imputed data sets.
Identifying Patient Groups Differentiated by Risk
of Adverse Event
The Figure depicts the ﬁnal tree generated with the CART
analysis including the rate of adverse events and number of
patients within each of the 6 discrete patient groups that were
generated (further details presented in Table 5). Of the 18
candidate risk factors entered in the analysis, CART identiﬁed
presence/absence of a neurodevelopmental condition (24%
risk among 307 patients) as the best single discriminator
between patients experiencing an adverse event or not. For
those without a neurodevelopmental condition, the next best
discriminator was whether the cardiac diagnosis was HLHS or
(functionally univentricular heart/pulmonary atresia with an
intact ventricular septum) (15.2% risk among 868 patients).
For patients with neither of the ﬁrst 2 risk factors, the next
best discriminator was presence/absence of a congenital
anomaly followed by the LOS (threshold 1 month) (8.6% risk
in patients with a congenital anomaly and LOS of <1 month,
24% in patients with congenital anomaly and LOS of
>1 month, and 9.3% in patients with no congenital anomaly
and LOS of >1 month). The remaining 4778 low-risk patients
with none of the above factors had an adverse event rate of
2.8%. The development and test sets had c-statistics of 0.73
and 0.74, respectively.
Discussion
Outcomes and Risk Factors
The causes of attrition after hospital discharge are poorly
understood compared with adverse events occurring in
hospital, yet as in-hospital care improves, these postdischarge
deaths are becoming increasingly numerically signiﬁcant. Of
7976 patients who had undergone an intervention for CHD in
infancy, representing the caseload for England and Wales over
a 6-year period, 333 (4.2%) died during their index admission.
Of those discharged alive, 246 (3.2%) died either outside the
specialist hospital or after an emergency unplanned PICU
readmission within 1 year (fatal adverse events). An additional
268 patients (3.6%) experienced unplanned urgent readmis-
sion to an intensive care unit but subsequently survived (“near
misses”), giving a combined total of 514 (6.7%) adverse
events. The data set was generated by linking 2 national
audits, each documenting variables potentially associated
with these postdischarge outcomes.
The following risk factors have previously been linked to
adverse postdischarge outcomes: primary diagnosis (in par-
ticular, HLHS and other diagnoses requiring an initial palliative
[staged] procedure34,35), noncardiac congenital anoma-
lies35,36, prematurity37, prolonged LOS35,36 (indicating greater
complexity and perhaps a surrogate for postprocedural
complications38), and ethnicity.5 The risk models in our study
further identiﬁed lower weight-for-age at procedure (which
may correlate with feeding difﬁculties in infancy, a known risk
factor39); additional acquired cardiac diagnoses and preoper-
ative clinical deterioration (which may relate to studies
indicating that severer forms of a given type of CHD are at
risk of poor postdischarge outcome5,40); neurodevelopmental
conditions (which may overlap with noncardiac anomalies);
and younger age at surgery (which, in contrast to studies
speciﬁcally relating to HLHS that indicate older age at surgery
increases risk of interstage death,41,42 may reﬂect a broader
effect such as young neonates being at higher risk than older
infants34,35).
Informing Quality Improvement
The data presented reﬂect outcomes within the context of
recent historical provision of services for infants with major
CHD and are potentially insightful for ongoing quality
improvement initiatives. To this end, we used CART analysis
to identify patient groups with different “proﬁles of risk” (ie,
deﬁned by both their level of risk and the nature of that risk)
who might beneﬁt from speciﬁc interventions. The 6 groups
that were identiﬁed have levels of risk of adverse event
between 3% and 24%, which is informative when considering
which groups may be a priority for intervention, while the
clinical characteristics underlying the risk of each patient
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Table 3. Final Logistic Regression Model for Fatal Adverse Events Only
Patient Variable Overall No. (%)
No. of (%) Fatal
Adverse Events Odds Ratio SE 95% CI
Ethnicity
White 5728 (75.0) 166 (2.9) Reference category
Mixed 196 (2.6) 4 (2.0) 0.68 0.35 0.25–1.88
Asian 867 (11.3) 38 (4.4) 1.38 0.26 0.95–2.01
Black 345 (4.5) 12 (3.5) 1.00 0.31 0.54–1.85
Chinese 28 (0.4) 3 (3.6) 1.46 1.53 0.19–11.43
Other 133 (1.7) 12 (9.0) 2.82 0.94 1.46–5.44
Not stated 346 (4.5) 13 (3.8) 1.53 0.47 0.85–2.78
Cardiac diagnosis group
VSD 1348 (17.6) 25 (1.9) Reference category
HLHS 390 (5.1) 48 (12.3) 3.07 0.97 1.65–5.71
UVH or PA+IVS 531 (7.0) 41 (7.7) 2.31 0.69 1.29–4.15
Other 5374 (70.3) 132 (2.5) 1.12 0.26 0.70–1.77
Specific procedure group
Corrective 4973 (65.1) 86 (1.7) Reference category
Palliative 1629 (21.3) 119 (7.3) 2.14 0.38 1.50–3.04
Ungrouped 1041 (13.6) 41 (3.9) 1.77 0.36 1.20–2.63
Congenital anomaly
No 6035 (79.0) 156 (2.6) Reference category
Yes 1608 (21.0) 90 (5.6) 2.43 0.37 1.81–3.27
Prematurity
No 4714 (61.7) 161 (3.4) Reference category
Yes 828 (10.8) 44 (5.3) 1.64 0.30 1.16–2.34
Clinical deterioration
No 6174 (80.8) 161 (2.6) Reference category
Yes 1469 (19.2) 85 (5.8) 1.66 0.24 1.25–2.22
Age at index procedure
>3 mo 3202 (41.9) 55 (1.7) Reference category
1–2 mo 1427 (18.7) 45 (3.2) 1.32 0.28 0.87–2.01
10–30 d 1114 (14.6) 43 (3.9) 1.89 0.45 1.19–3.02
0–10 d 1900 (24.9) 103 (5.4) 2.54 0.60 1.61–4.03
Weight-for-age z-score
>2 SDs 4064 (53.2) 128 (3.1) Reference category
2 to 4 SDs 2467 (32.3) 71 (2.9) 1.59 0.28 1.12–2.26
<4 SDs 584 (7.6) 19 (3.3) 2.28 0.61 1.34–3.87
Index length of stay
0–7 d 2564 (33.5) 35 (1.4) Reference category
7–30 d 4327 (56.6) 146 (3.4) 1.56 0.31 1.06–2.31
>1 mo 752 (9.8) 65 (8.6) 2.70 0.63 1.71–4.26
Details of the ﬁnal regression model for fatal adverse events (death within a year after discharge from the index admission and not during a planned admission). For each patient variable
the number (percentage) of fatal adverse events, multivariable odds ratios, standard errors and 95% conﬁdence intervals are presented and the reference category indicated. The overall
number (percentage) of patients within each category for a given patient variable is also noted. HLHS indicates hypoplastic left heart syndrome; PA+IVS, pulmonary atresia with an intact
ventricular septum; PICU, pediatric intensive care unit; UVH, functionally univentricular heart; VSD, ventricular septal defect.
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Table 4. Final Logistic Regression Model for Adverse Event
Patient Variable
Overall
Number (%)
Number (%)
Adverse Events OR SE 95% CI
Ethnicity
White 5728 (75.0) 348 (6.1) Reference category
Mixed 196 (2.6) 9 (4.6) 0.63 0.23 0.31–1.29
Asian 867 (11.3) 73 (8.4) 1.21 0.17 0.92–1.61
Black 345 (4.5) 34 (9.9) 1.43 0.29 0.96–2.12
Chinese 28 (0.4) 1 (3.6) 0.65 0.68 0.09–5.02
Other 133 (1.7) 19 (14.3) 2.39 0.65 1.40–4.08
Not stated 346 (4.5) 30 (8.7) 1.76 0.37 1.16–2.65
Cardiac diagnosis group
VSD 1348 (17.6) 60 (4.5) Reference category
HLHS 390 (5.1) 70 (18.0) 2.46 0.58 1.55–3.90
UVH or PA+IVS 531 (7.0) 73 (13.8) 2.15 0.46 1.41–3.28
Other 5374 (70.3) 311 (5.8) 1.20 0.19 0.88–1.64
Specific procedure group
Corrective 4973 (65.1) 219 (4.4) Reference category
Palliative 1629 (21.3) 205 (12.6) 1.65 0.21 1.28–2.13
Ungrouped 1041 (13.6) 90 (8.7) 1.61 0.22 1.23–2.11
Congenital anomaly
No 6035 (79.0) 305 (5.1) Reference category
Yes 1608 (21.0) 209 (13.0) 2.71 0.29 2.19–3.35
Neurodevelopment condition
No 7336 (96.0) 439 (6.0) Reference category
Yes 307 (4.0) 75 (24.4) 2.81 0.44 2.06–3.82
Prematurity
No 4714 (61.7) 340 (7.2) Reference category
Yes 828 (10.8) 93 (11.2) 1.59 0.21 1.22–2.06
Acquired diagnosis
No 7164 (93.7) 457 (6.4) Reference category
Yes 479 (6.3) 57 (11.9) 1.85 0.30 1.35–2.53
Age at index procedure
>3 months old 3202 (41.9) 129 (4.0) Reference category
1–2 months old 1427 (18.7) 110 (7.7) 1.59 0.23 1.20–2.10
10–30 days 1114 (14.6) 90 (8.1) 2.21 0.37 1.59–3.06
0–10 days old 1900 (24.9) 185 (9.7) 2.93 0.48 2.12–4.04
Weight-for-age z-score
>2SD 4064 (53.2) 243 (6.0) Reference category
2 to 4 SD 2467 (32.3) 168 (6.8) 1.72 0.22 1.34–2.21
<4SD 584 (7.6) 50 (8.6) 2.60 0.48 1.81 to 3.75
Index length of stay
0–7 days 2564 (33.5) 84 (3.3) Reference category
7–30 days 4327 (56.6) 302 (7.0) 1.54 0.21 1.19–2.00
>1 month 752 (9.8) 128 (17.0) 2.73 0.44 1.99–3.75
Details of the ﬁnal regression model for adverse event (either death or an emergency unplanned readmission to PICU within 1 year after discharge from the index admission). For each
patient variable, the number (percentage) of adverse events, the multivariable odds ratios, SEs, and 95% CIs are presented and the reference category indicated. The overall number
(percentage) of patients within each category for a given patient variable is also noted. HLHS indicates hypoplastic left heart syndrome; PA+IVS, pulmonary atresia with an intact ventricular
septum; PICU, pediatric intensive care unit; UVH, functionally univentricular heart; VSD, ventricular septal defect.
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group (deﬁned in terms of neurodevelopmental conditions;
cardiac diagnosis of HLHS, functionally univentricular heart, or
pulmonary atresia with an intact ventricular septum; congen-
ital anomalies; LOS >1 month) can inform the type of
intervention that might be most appropriate. For example,
group 3 consists of those patients most widely recognized as
vulnerable to late death and offered enhanced surveillance,
namely patients with cardiac diagnoses of HLHS and other
functionally univentricular heart conditions.43 For example,
single-center studies from the United States7,8,43 and Ger-
many9 suggest that postdischarge packages for HLHS (home
monitoring programs) reduce interstage mortality. However,
groups 1 and 2 have a higher occurrence of adverse events,
suggesting that it may also be important to mitigate risks
arising from patient factors beyond cardiac diagnosis, in
particular clinically signiﬁcant neurodevelopmental conditions
and congenital anomalies. The type of intervention appropri-
ate for these typically complex and lifelong comorbidities may
be very different from those currently aimed at mitigating the
cardiac risk of functionally single-ventricle and shunt-depen-
dent infants.
Strengths and Weaknesses
The national audit data underpinning this study offer a unique
opportunity for a population-based analysis of surgically
treated infants with CHD. First, the data are of high quality
as demonstrated by the results of a regular systematic
independent validation process.14,15 Second, the NHS number
enabled late deaths outside treatment centers to be reliably
ascertained by using life status tracking and enabled linkage
between the two national audit data sets allowing their
N = 514 / 7,643
6.7%
Neurodevelopmental condion?
No Yes
Group 1
N = 75 / 307
24.4%
Primary cardiac diagnosis
VSD / Other HLHS / (UVH or PA)
Congenital anomaly?
Yes No
Group 3
N = 132 / 868
15.2%
N = 307 / 6,468
4.7%
< 1 month > 1 month
N = 144/ 1366
10.5%
Length of stay (index admission)
< 1 month > 1 month
N = 439 / 7,336
6.0%
N = 163 / 5,102
3.2%
Group 5 
N = 103 / 1195
8.6%
Group 2
N = 41 / 171
24.0%
Group 6
N = 133 / 4,778
2.8%
Group 4
N = 30 / 324
9.3%
Group Number
N = Number of adverse events in Group / 
Total number in Group
Rate of adverse events in Group
Length of stay (index admission)
Figure. Classiﬁcation and regression tree (CART) analysis. The stratiﬁcation tree generated by the CART analysis and evaluated across the
entire data set (see Table 5 for a breakdown by development and test set). The number and rate of adverse events and the total number of
patients are given for each node. HLHS indicates hypoplastic left heart syndrome; PA, pulmonary atresia; UVH, functionally univentricular heart;
VSD, ventricular septal defect.
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respective, and complementary, content to be used. Third,
mandatory data submission means that all procedures for
CHD are captured, the only exclusions being patients who
traveled from overseas speciﬁcally for treatment (since these
do not have an NHS number and would not form part of the
follow-up program for UK specialist centers); patients in
NCHDA who could not be linked to any records in PICANet
(which includes those cared for only in neonatal units, those
with a missing NHS number in PICANet, and those who did
not require intensive care admission in either a neonatal unit
or PICU for the procedure), and who represent predominantly
more minor forms of CHD including a large proportion of PDA-
only procedures and patients who are provided with follow-up
by other specialist teams (eg, transplant recipients, premature
infants without CHD). Our ﬁndings may therefore be consid-
ered more generalizable than those based on single-center
studies or those from a more limited geographical area.
There are inherent limitations to using registry-based data,
including the inevitable reliance on the data items that were
routinely captured, which did not incorporate every potential
variable of interest. Examples of important data that we could
not access include the presence of residual lesions such as
atrioventricular valve regurgitation, which is a known risk
factor for late death in HLHS,5 and information that is
available later in the patient journey from outside the hospital
such as weight gain, which is linked to late outcome.39 There
was a need to form tractable groupings from the vast range of
diagnostic and procedure codes available to reduce the
degrees of freedom for statistical analyses. Given our primary
objective to inform quality improvement initiatives directed
against late deterioration and death, we prioritized identiﬁca-
tion of diagnoses known to be high risk, namely HLHS and
functionally single-ventricle patients.
Our study outcomes inevitably reﬂect recent health
services speciﬁc to the United Kingdom as provided by the
NHS and, further, relate to the English and Welsh populations
in terms of ethnicity, which has known links to the distribution
of congenital anomalies.44 Evidence from North American
studies suggests higher mortality for infants with CHD from
Black and Hispanic ethnic groups, this being linked to reduced
access to care45–48; however, these ethnic groupings are not
representative of our study population. The ethnicity category
“Other” in our data set was found to be at greater
multivariable risk of adverse late outcome, whereas the more
prevalent Asian and Black ethnic groups were not. Information
from the UK Census suggests this category is largely
comprised of individuals born in the Far East (Philippines,
Japan, Thailand, and Vietnam), Middle East, and North
Africa.49 Infants with CHD from these ethnic groups could
be in newly immigrant families where treatment may occur
later in the disease process or access to care may be
compromised for cultural or linguistic reasons. Interestingly,
in our analysis, socioeconomic status (English index of
multiple deprivation17) was not associated with outcome, in
contrast to related data from North America.5,37
Conclusion
Our ﬁndings demonstrate that later unexpected deaths are
comparable in scale to early deaths after major intervention
for CHD and that, while further improvements in early
mortality are possible and important, there may arguably be
a diminishing return to improvement initiatives in the
perioperative period compared with the postdischarge period
because of the relative lack of attention to the latter to date.
We note that guidelines for the entire discharge process in
“high-risk infants” (not including CHD) have been proposed by
the American Academy of Pediatrics with the aim of reducing
variability and maintaining predetermined levels of care,50 and
our study suggests that something similar is warranted for
CHD. This would require the development of appropriate
intervention packages for patients with different needs, and
our ﬁndings provide a valuable starting point in designing
these. In particular, they show that adverse late outcomes are
not conﬁned to diagnostic groups currently targeted with
enhanced monitoring in some services (ie, HLHS patients) and
that subgroups of patients with neurodevelopmental condi-
tions or congenital anomalies could also beneﬁt from targeted
intervention. Finally, to stimulate improvement initiatives
aimed at reducing late adverse outcomes and to align activity
across organizations responsible for the care of these
patients, 1-year outcome after intervention for CHD in infancy
may be a useful quality metric for pediatric cardiac surgery
programs to complement the current focus on early mortality
rates of surgery at 30 days or hospital discharge.
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SUPPLEMENTAL MATERIAL 
 
 
Data S1. Supplemental Methods 
 
Specific procedure hierarchy and groupings 
 
Within the NCHDA dataset, each procedure is described by up to 8 individual procedural 
International Paediatric and Congenital Cardiac Codes (IPCCCs) [1]. An algorithm developed by the 
NCHDA Steering Committee links the individual IPCCCs for a given record to 1 of 56 specific 
procedures, i.e. reported surgical operations or transcatheter procedures. Note that the hierarchical 
system is shown here in its entirety for reference purposes. It is designed for children of any age and 
many procedures listed would be rarely if ever performed in infancy.  
 
The algorithm imposes a hierarchy with the record assigned the most complex specific procedure 
consistent with the collection of codes recorded. Approximately 85% of procedures fall into one of 
these 56 specific procedures. For children that had more than one procedure during their index 
admission, their index intervention was chosen to be the most complex according to the NCHDA 
specific procedure hierarchy.    
 
For reasons of model reliability and validity of predictive discrimination, the index specific 
procedures were aggregated into three procedural groups considered clinically meaningful to the 
focus of the study: definitive, staged and ungrouped. A definitive procedure would be expected to be 
the final, often only, operation in achieving a biventricular or functionally univentricular circulation, 
although acknowledging that later procedures may be required in an individual’s lifetime, such as 
conduit or valve replacement. A staged procedure would be undertaken in the expectation that further 
operations would be expected to achieve either a definitive biventricular circulation or definitive 
univentricular repair with a Fontan-type operation in early childhood.   
 
Specific procedure NCHDA hierarchy Procedure group 
Norwood 1 Staged 
Heart Transplant 2 Excluded 
Totally anomalous pulmonary venous connection (TAPVC) 
Repair + Arterial Shunt 3 Staged  
Fontan procedure † 4 Staged  
Bidirectional cavopulmonary shunt 5 Staged  
Senning or Mustard procedure 6 Staged  
Truncus and interruption repair 7 Definitive 
Truncus arteriosus repair 8 Definitive 
Tricuspid valve replacement 9 Ungrouped 
Interrupted aortic arch repair 10 Definitive 
Multiple ventricular septal defect (VSD) closure 11 Definitive 
Mitral valve replacement 12 Definitive 
Repair of TAPVC 13 Definitive 
Atrioventricular septal defect and tetralogy repair 14 Definitive 
Atrioventricular septal defect (complete) repair 15 Definitive 
Atrioventricular septal defect (partial) repair 16 Definitive 
Aortic valvotomy (surgical) 17 Definitive 
Aortic valvoplasty 18 Definitive 
Anomalous coronary artery repair 19 Definitive 
Cor triatriatum repair 20 Definitive 
Arterial switch + VSD closure 21 Definitive 
Arterial switch (for isolated transposition) 22 Definitive 
Pulmonary atresia & VSD repair 23 Definitive 
Pulmonary valve replacement 24 Definitive 
Tetralogy with absent pulmonary valve repair 25 Definitive 
Tetralogy repair 26 Definitive 
Isolated coarctation repair 27 Definitive 
Aortic Valve Replacement - non Ross 28 Definitive 
Supravalvar aortic stenosis repair 29 Definitive 
Rastelli procedure 30 Definitive 
Aortic valve replacement - Ross 31 Definitive 
Aortic root replacement (not Ross) 32 Definitive 
Subvalvar aortic stenosis repair 33 Definitive 
Aortopulmonary window repair 34 Definitive 
Atrial septal defect (ASD) repair 35 Definitive 
VSD Repair 36 Definitive 
Arterial shunt 37 Staged  
Isolated Pulmonary artery band 38 Staged  
Patent ductus arteriosus (PDA) ligation (surgical) 39 Definitive 
Transcatheter pulmonary valve replacement * 40 Excluded 
VSD closure (catheter) * 41 Excluded 
Aortic balloon valvotomy 42 Definitive 
Coarctation angioplasty 43 Definitive 
Pulmonary artery stenting * 44 Excluded 
ASD closure (catheter) * 45 Excluded 
PDA closure (catheter) 46 Definitive 
Recoarctation angioplasty * 47 Excluded 
Pulmonary balloon valvoplasty 48 Definitive 
Blade atrial septostomy * 49 Excluded 
Coarctation stenting 50 Definitive 
PFO closure (catheter) * 51 Excluded 
Pulmonary valvotomy (radiofrequency) 52 Definitive 
Duct Stenting 53 Staged  
RVOT Stenting 54 Staged  
Radiofrequency ablation for supraventricular tachycardia * 55 Excluded 
Implantable Cardioverter Defibrillator * 56 Excluded 
Minor and Excluded Procedures * 57 Excluded 
Not a specific procedure: surgical ** 58 Ungrouped 
Not a specific procedure: catheter * 59 Excluded 
* Catheter procedure excluded from analysis 
** Note that n=53 out of 231 children with a cardiac diagnosis of aortic arch obstruction +/- VSD/ASD and no 
index specific procedure had either a banding of pulmonary trunk or pulmonary trunk band removal and were 
therefore classified as a “staged” procedure group rather than “ungrouped”. 
† Only one patient in our infant cohort had a Fontan as their index procedure. 
 Candidate patient risk factors 
 
Potential non-medical, pre-procedure or post- procedure risk factors available in the patient-based 
analysis dataset that would be known at the point of discharge were pre-specified (Supplemental 
Table 1). Some variables were simplified prior to the statistical analyses in order to reduce the number 
of values (degrees of freedom) in the model and hence the risk of overfitting (see Harrell [2]). An 
appropriate power calculation was performed. The origin of each risk factor (either the PICANet or 
NCHDA dataset) is noted in Supplemental Table 1. Where both audits contained information on a 
particular risk factor, the most complete source was used or, in the case of ethnicity, a combination of 
the two sources (see Supplemental Table 1).  
 
Non-medical variables 
 
Deprivation was based on the residential address at admission and defined using quintiles of the 
English Index of Multiple Deprivation 2010 (IMD), which is calculated at the level of small (~ 1,500 
people) geographic areas covering England [3]. 
 
Ethnicity information is recorded in both audits, with NCHDA using a bespoke classification scheme 
and PICANet using the Census 2001 classification used by the Office for National Statistics (ONS) 
[4]. PICANet was the primary source for our ethnicity variable due to its comparability with 
population statistics and was collapsed into seven groups to improve model stability: white, mixed, 
Asian, black, Chinese, other, and not stated. Where ethnic group was not available from PICANet, the 
NCHDA ethnic code was used to assign white, Asian or black ethnicity (which showed strong 
concordance across the two audits) but not to assign Chinese, other or mixed ethnicity (which showed 
poorer concordance) [5]. The most frequently recorded ethnic group was assigned to the child if they 
had multiple admission records. 
 
Pre-procedure variables 
 
Cardiac diagnoses and procedure information 
 
Within the NCHDA dataset, each record (interventional procedure) can be described by up to 6 
individual diagnostic International Paediatric and Congenital Cardiac Codes (IPCCCs). The 
combination of these can be mapped to 1 of 24 primary cardiac diagnoses using a hierarchical scheme 
developed by Brown et al. [6]. For the purposes of this study, this mapping scheme was implemented 
with two minor adjustments (see Supplemental Table 2): a new category of ‘arrhythmia’ was created 
(ranked 24th in the modified hierarchy) and the “miscellaneous congenital” diagnostic category was 
split into “major miscellaneous diagnoses” (ranked 9th in the modified hierarchy) and “minor 
miscellaneous diagnoses” (ranked 25th in the modified hierarchy).  
 
To reduce the risk of overfitting in the model, we grouped the diagnostic categories into four cardiac 
diagnosis groups (see Supplemental Table 2): Hypoplastic left heart syndrome (HLHS); Functionally 
univentricular heart (UVH) or pulmonary atresia (PA) with an intact ventricular septum (IVS); 
Ventricular septal defect (VSD) and; “Other” (the remaining 22 diagnosis categories).  
The choice of diagnosis group ‘HLHS’ reflects the body of literature related to ‘inter-stage’ deaths in 
this population. A separate group of ‘UVH or PA+IVS’ was chosen due to the high-risk nature of 
these conditions, which are often systemic-to-pulmonary arterial shunt dependent, with a view to 
distinguishing these from HLHS patients. Of the remaining cardiac diagnosis groups, we elected to 
review the VSD group separately as a recognizable bi-ventricular comparator group in order for us to 
evaluate the face validity of comparisons between HLHS or UVH/PA+IVS and the much larger, less 
homogeneous group of mainly biventricular diagnoses. 
 
In addition to their overall primary cardiac diagnosis, each child was identified as having an acquired 
cardiac diagnosis if any of their records included an IPCCC diagnostic code mapping to this category, 
for example, ventricular dysfunction and ventricular hypoplasia. Some non-cardiac IPCCC diagnostic 
codes were identified as post-procedural morbidities (see below and Supplemental Table 4 for 
details).  
 
The index (specific) procedures were aggregated into three groups (see above for mappings): 
Palliative (e.g. Norwood, bidirectional cavopulmonary shunt, arterial shunt), Corrective (e.g. truncus 
arteriosus repair, atrioventricular septal defect complete repair, tetralogy repair) or “Ungrouped” (if 
no specific procedure was assigned).  
 
Non-cardiac diagnosis and co-morbidity information 
 
Non-cardiac diagnosis and co-morbidity information was primarily sourced from PICANet, in which 
any given PICU admission can record up to 24 clinical Read codes [7]. As 3,325 discrete Read codes 
were present in the dataset, we developed a new scheme linking each code to 1 of 16 system-based 
categories (see Supplemental Table 3).  
 
Congenital anomaly: If any PICU admission within the index admission contained a Read code for a 
congenital anomaly then the child was assigned this attribute. Many of these children had Downs 
syndrome, however other syndromes that are often associated with cardiac defects were also often 
represented, including DiGeorge syndrome (22q11 deletion). Non-syndromic congenital anomalies 
were also described, including urogenital/renal malformations, tracheal/trachea-oesophageal 
malformations, vision/hearing deficits and exomphalos/gastrointestinal malformations. These are 
major anomalies, some requiring neonatal surgery, and their impact is likely to be life-long.  
 
Neurodevelopmental condition: If any Read code within the index admission was linked to the 
neurodevelopmental category then the child was assigned this attribute. These comprised a range 
acquired and congenital conditions most with global effects on the central nervous system and likely 
to have lifelong impact, the most common examples being (in order of decreasing frequency): 
epilepsy/seizures, developmental delay, sleep apnoea, hydrocephalus, retinopathy of prematurity, 
stroke, hemiparesis/hemiplegia, anoxic encephalopathy, cerebral venous sinus thrombosis and 
cerebral palsy. Within the analysis dataset, n= 95 children were coded as having developmental delay, 
of which n=64 had no other neurodevelopmental problem coded. On closer inspection of these n=64 
children, 41% had a congenital anomaly or syndrome (e.g. Down’s syndrome, DiGeorge syndrome, 
craniosynostosis, microcephaly) or a comorbidity (e.g. meningitis, preterm birth, brain injury) that 
could be associated with developmental delay. The remaining 59% had no record of a comorbidity 
associated with developmental delay but since coding is not comprehensive (e.g. preterm children 
were not always recorded as such), it is possible that these are nonetheless correct and were used 
where a degree of neurodevelopmental delay was evident even within infancy. 
 
Prematurity: Finally, a child was assigned the attribute of prematurity (<37 completed weeks 
gestation) if they had a Read code for this in any admission.  
 
Additional pre-procedure factors 
 
Additional pre-procedure factors considered on the basis of potential clinical relevance were: Gender; 
Age at procedure; Weight-for-age at procedure (calculated using WHO reference standards [7]); 
Antenatal diagnosis, Clinical deterioration prior to the index intervention (assigned if the index 
admission or any prior PICU admissions were urgent and unplanned). 
 
Post-procedure variables 
 
Post-procedure patient variables known at hospital discharge were: Length of stay for the index 
admission; Requirement for renal support (including dialysis and haemofiltration) or extracorporeal 
membrane oxygenation support (ECMO) during the index admission; Any adverse ICU events during 
the index admission (assigned if any PICU admission contained a Read code for: collapse or cardiac 
arrest, acquired injury or complications, or a non-cardiac operation (categories 9-11 in Supplemental 
Table 3)); Whether the index admission was associated with any acquired co-morbidities (categories 
1-8 in Supplemental Table 3); Whether the index admission was associated with any post-procedural 
morbidity (Supplemental Table 4); Any catheter or surgical procedures performed during the index 
admission in addition to the index procedure (either before or after the index procedure). 
 
 
 
Table S1: Summary of candidate patient risk factors 
Descriptions of the pre-specified potential risk factors considered in the analysis, including whether a given variable relates to the index procedure, index 
admission or is a characteristic of the child, its possible values and the source dataset (PICANet or NCHDA). All variables would be known at the point of 
discharge and are grouped according to whether they are a non-medical, pre-procedure or post- procedure factor. 
 
Pre-specified 
candidate risk factor Description 
Variable 
level Values 
Source 
dataset 
Non-medical     
Deprivation  Quintiles of the English Index of Multiple Deprivation 2010 [2] as 
recorded for the index procedure. 
Child 1-5 (1 most deprived, 
5 least deprived) 
NCHDA 
Ethnicity Census 2001 classification used by ONS [3], collapsed into seven groups. 
Most frequently recorded ethnic group if child had multiple records. 
Child White, Mixed, Asian, 
Black, Chinese, 
Other, Not stated 
PICANet† 
Pre-procedure     
Cardiac diagnosis group Aggregated groupings of the cardiac diagnosis categories assigned 
through application of a modified version of the hierarchical mapping 
scheme developed by Brown et al.[5] across all cardiac records for a child 
(see Table A2). 
Child VSD, HLHS, 
UVH/PA+IVS, Other 
NCHDA 
Acquired cardiac 
diagnosis 
Assigned if any cardiac record in the index admission had an IPCCC 
diagnostic code corresponding to the acquired cardiac diagnosis category 
(see Table A2). 
Index 
admission 
Yes, No NCHDA 
Specific procedure 
group  
Aggregated groupings of the index specific procedures assigned through 
application of the NCHDA specific procedure hierarchy across all 
interventions within the index admission (see Appendix 1).  
Index 
procedure 
Corrective, 
palliative, ungrouped 
NCHDA 
Congenital anomaly Assigned if any PICU record during the index admission contained a Read 
code corresponding to the congenital anomaly category. 
Index 
admission 
Yes, No, PICANet 
Neurodevelopment 
condition 
Assigned if any PICU record during the index admission contained a Read 
code corresponding to the neurodevelopmental category. 
Index 
admission 
Yes, No PICANet 
Prematurity Assigned if any PICU record for the child contained a Read code 
corresponding to prematurity or preterm birth (see Table A3). 
Child Yes, No, Missing PICANet 
Gender Most frequently occurring gender across all cardiac records for a patient 
(or gender at index procedure if tied). 
Child Male, Female NCHDA 
Age at index procedure Age recorded in cardiac record for the index procedure. Index 
procedure 
Continuous variable NCHDA 
Weight-for-age z-score Standardised weight-for-age at index procedure, calculated from index 
procedure weight and age using WHO reference standards [6]. 
Index 
procedure 
Continuous variable NCHDA 
Antenatal diagnosis Assigned if coded in any cardiac record for the child. Child Yes, No, Missing NCHDA 
Clinical deterioration Assigned if any PICU admissions prior to discharge from the index 
admission were urgent and unplanned. 
Index 
admission 
Yes, No PICANet 
Post-procedure     
Length of stay  The length in days of the continuous period as in-patient within a 
specialist paediatric cardiac hospital or PICU that surrounds a child’s first 
interventional cardiac procedure in infancy. 
Index 
admission 
Continuous variable NCHDA 
& 
PICANet 
Need for renal support Assigned if any PICU record within the index admission indicated renal 
support was required (including dialysis and haemofiltration). 
Index 
admission 
Yes, No, Missing PICANet 
Need for ECMO Assigned if any PICU record within the index admission indicated ECMO 
support was required. 
Index 
admission  
Yes, No, Missing PICANet 
Acquired comorbidity Assigned if any PICU record during the index admission contained a Read 
code identified an acquired condition (categories 1-8 in Table A3). 
Index 
admission 
Yes, No, Missing PICANet 
Adverse event in PICU Assigned if any PICU record during the index admission contained a Read 
code corresponding to collapse or cardiac arrest, acquired injury or 
complications, or a non-cardiac operation in PICU (categories 9-11 in 
Table A3). 
Index  
admission 
Yes, No, Missing PICANet 
Post-procedural 
morbidity 
Assigned if any cardiac record during the index admission contained an 
IPCCC code identified as a post-procedural morbidity (see Table A4). 
Index 
admission 
Yes, No NCHDA 
Additional surgical 
procedures 
Assigned if any surgical procedures were performed during the index 
admission in addition to the index procedure (before or after). 
Index 
admission 
Yes, No NCHDA 
Additional catheter 
procedures 
Assigned if any catheter procedures were performed during the index 
admission in addition to the index procedure (before or after). 
Index 
admission 
Yes, No NCHDA 
 
ONS = Office for National Statistics; PICU = paediatric intensive care unit; NCHDA = National Congenital Heart Disease Audit; PICANet = Paediatric Intensive Care Audit 
Network; IPCCC = International Paediatric and Congenital Cardiac Code; ECMO = extracorporeal membrane oxygenation; HLHS = hypoplastic left heart syndrome; UVH = 
functionally univentricular heart; PA+IVS = pulmonary atresia with intact ventricular septum; VSD = Ventricular septal defect. 
† Where ethnic group was not available from PICANet, the NCHDA ethnic code was used to assign white, Asian or black ethnicity (which showed strong concordance across 
the two audits) but not to assign Chinese, other or mixed ethnicity (which showed poorer concordance).
Table S2: Primary cardiac diagnosis hierarchy and collapsed groupings 
The hierarchy used to assign a primary cardiac diagnosis category to each child in the analysis dataset 
(modified from scheme developed by Brown et al.[5]), along with the mappings from diagnosis 
category to cardiac diagnosis group (the candidate patient risk factor used in the analyses). 
 
Primary cardiac diagnosis category Hierarchy rank† 
Cardiac diagnosis 
group†† 
Hypoplastic left heart syndrome 1 HLHS 
Functionally univentricular heart 2 UVH or PA+IVS 
Common arterial trunk (truncus arteriosus) 3 Other 
TGA + VSD/DORV-TGA type 4 Other 
Interrupted aortic arch 5 Other 
TGA (concordant AV and discordant VA connections) and 
intact ventricular septum 6 Other 
PA with an intact ventricular septum 7 UVH or PA+IVS 
Pulmonary atresia + VSD (including Fallot type) 8 Other 
Miscellaneous congenital primary diagnoses 9 Other 
Atrioventricular septal defect 10 Other 
Fallot/DORV-Fallot type 11 Other 
Aortic valve stenosis (isolated) 12 Other 
Tricuspid valve abnormality (including Ebstein’s) 13 Other 
Mitral valve abnormality (including supravalvar, subvalvar) 14 Other 
Totally anomalous pulmonary venous connection 15 Other 
Aortic arch obstruction +/- VSD/ASD 16 Other 
Pulmonary stenosis 17 Other 
Subaortic stenosis (isolated) 18 Other 
Aortic regurgitation 19 Other 
Isolated VSD +/- ASD +/- PDA 20 VSD 
Interatrial communication (ASD) 21 Other 
Patent ductus arteriosus (PDA) 22 Other 
Acquired non-congenital heart disease 23 Other 
Arrhythmia 24 Other 
Miscellaneous congenital terms 25 Other 
Noncardiac or uncoded diagnosis 26 Other 
 
TGA = transposition of the great arteries; VSD = ventricular septal defect; DORV = double outlet right 
ventricle; AV = atrioventricular; VA = ventriculoarterial; ASD = atrial septal defect. 
† The hierarchical scheme developed by Brown et al.[5], modified for the purposes of this study with two minor 
adjustments: creating a new category of ‘arrhythmia’ and splitting the original “miscellaneous congenital” 
diagnostic category into “major miscellaneous diagnoses” and “minor miscellaneous diagnoses”. 
†† For reasons of model reliability and validity of predictive discrimination, we grouped the diagnostic 
categories into four cardiac diagnosis groups considered clinically meaningful to the study focus: Hypoplastic 
left heart syndrome (HLHS); Functionally univentricular heart (UVH) or pulmonary atresia with an intact 
ventricular septum (PA+IVS); Ventricular septal defect (VSD); “Other”. 
Table S3: Coding scheme for non-cardiac diagnoses and comorbidities 
A new scheme developed and implemented in this work to link each Read code [6] to at most 1 of 16 
system-based categories. Given the large number of codes, we present exemplars within each of 
categories rather than the extensive list: further details are available from authors on request. We note 
that congenital heart disease/cardiac procedure Read codes in PICANet were not included as a 
category as they were inconsistently recorded. Cardiac diagnostic and procedure codes for the 
analysis were derived from the NCHDA dataset only. 
 
 Category Number of codes 
Examples of included clinical 
conditions 
1 Acquired endocrine, nutritional and metabolic conditions 82 
Diabetes mellitus; alpha-1-antitrypsin 
disorder; rickets; failure to thrive 
2 Acquired gastrointestinal (digestive system) conditions 166 
Gastritis; constipation; liver failure; 
hernia; jaundice; perianal fistula 
3 
Acquired infections (in any system 
except respiratory infections which 
are included within the category for 
acquired respiratory system 
conditions) 
144 
Cytomegalovirus; E coli infection; 
MRSA; meningitis; otitis media; wound 
abscess 
4 
Conditions related to haematology, 
oncology or immunology, which may 
be acquired or congenital. 
97 Acute myeloid leukaemia; Factor VIII deficiency; teratoma; sickle cell anaemia 
5 Acquired musculoskeletal, connective tissue or skin conditions 29 
Atopic dermatitis; scoliosis; systemic 
onset juvenile chronic arthritis 
6 Acquired genitourinary system conditions 42 
Acute renal failure; hydronephrosis; 
rectovaginal fistula   
7 Acquired respiratory system conditions 229 
Stridor; asthma; bronchiolitis; 
pulmonary oedema; pneumonia; 
haemothorax 
8 Conditions originating in or specific to the perinatal period 109 
Birth asphyxia; gestational diabetes; 
meconium ileus; shoulder dystocia 
9 
Non-cardiac intervention or 
operation, excluding procedures that 
are part of routine intensive care 
478 
Adenoidectomy; bone marrow 
transplant; splenectomy; plication of 
diaphragm 
10 Collapse or cardiac arrest 14 Cardiac arrest; hypovolaemic shock; fainting; respiratory arrest 
11 Acquired injury or complication of surgery/other condition 145 
Brain injury; anaesthetic shock; closed 
rib fracture; vocal cord palsy; limb 
ischaemia  
12 Congenital anomalies (all severity) 342 
Trisomy 18; Pierre-Robin syndrome; 
cleft palate; club foot; oesophageal 
atresia 
13 
Neurological or neurodevelopmental 
conditions – may be congenital or 
acquired 
126 
Cataract, cerebral palsy; autistic 
spectrum disorder; epilepsy; optic 
atrophy 
14 
Additional codes which are non-
specific or do not have standardised 
coding 
429 e.g. family history of hypothyroidism; child in foster care; central line feeding;  
15 Premature birth (<37 completed weeks gestation)  11 Baby born premature/very premature 
16 Supportive procedures 7 Extracorporeal membrane oxygenation (ECMO); ventricular assist device 
  
Table S4: Post-procedural morbidities 
Some non-cardiac diagnostic International Paediatric and Congenital Cardiac Codes (IPCCC) were 
identified as post-procedural morbidities as set out in the table below. If any NCHDA record during 
the index admission period for a child contained an IPCCC corresponding to a post-procedural 
morbidity then their index admission was flagged as having a post-procedural morbidity. 
 
IPCCC identified as post-procedural morbidities 
160101. Pneumothorax 
160104. Pleural effusion 
160107. Chylothorax 
100811. Postpericardiotomy syndrome 
110412. Junctional ectopic tachycardia (His bundle): post-op 
110617. Postprocedural complete AV block 
110632. Procedure related complete AV block requiring temporary pacing 
110633. Procedure related complete AV block requiring permanent pacemaker system 
150001. Cardiac arrest during procedure 
150002. Cardiac arrest following procedure 
150003. Postprocedural low cardiac output 
150005. Myocardial infarction following procedure 
150009. Postprocedural requirement for mechanical circulatory support 
150030. Postprocedural hypovolaemia 
150200. Postprocedural haemorrhage 
150203. Postprocedural coagulopathy 
150207. Postprocedural haemolysis 
150265. Postprocedural haemorrhage requiring reoperation 
150300. Median sternotomy complication 
150303. Infection of median sternotomy wound 
150308. Dehiscence of median sternotomy wound 
150315. Keloid-hypertrophic scar of median sternotomy wound 
150330. Lateral thoracotomy complication 
150332. Infection of lateral thoracotomy wound 
150350. Wound infection 
150351. Wound dehiscence 
150352. Mediastinitis 
152420. Postprocedural femoral arterial complication 
154306. Unplanned reoperation during current admission 
155000. Cardiac catheterisation complication 
155001. Intramyocardial injection of contrast medium 
155003. Perforation of cardiac chamber-vessel during cardiac catheterisation 
155011. Lost pulse after cardiac catheterisation 
155030. Equipment problem during cardiac catheterisation 
155037. Embolisation of catheter introduced device 
155040. Failed attempt to implant coil-device during transcatheter intervention 
155060. Complication involving device implantation 
155070. Complication involving stent 
155702. Extracorporeal Membrane Oxygenation (ECMO) circuit complication 
155703. Ventricular assist device complication 
155721. Intraaortic balloon pump (IABP) complication 
155801. Complication related to echocardiographic procedure 
155900. Medication related complication or error 
156002. Arrhythmia following procedure 
156738. Wound related complication 
157700. Cardiopulmonary bypass complication 
158000. General systemic complication of cardiac procedure 
158001. Postprocedural metabolic derangement 
158005. Postprocedural septicaemia 
158006. Capillary leak syndrome 
158015. Postprocedural acidosis 
158016. Multiple organ dysfunction syndrome (MODS) 
158019. Systemic inflammatory response syndrome (SIRS) 
158020. Respiratory complication after cardiac procedure 
158021. Postprocedural pulmonary infection 
158022. Postprocedural pulmonary hypertensive crises 
158029. Postprocedural Acute Respiratory Distress Syndrome (ARDS) 
158031. Postprocedural lung collapse (atelectasis) 
158032. Postprocedural requirement for mechanical respiratory support > 7 days 
158033. Postprocedural requirement for reintubation 
158050. Postprocedural pleural effusion 
158051. Postprocedural right pleural effusion 
158052. Postprocedural left pleural effusion 
158055. Postprocedural chylothorax 
158056. Postprocedural haemothorax 
158061. Pleural effusion requiring drainage 
158062. Postprocedural pneumothorax 
158070. Postprocedural complication involving tracheo-bronchial tree 
158086. Postprocedural requirement for tracheostomy 
158087. Postprocedural bronchial compression 
158090. Intraprocedural phrenic nerve injury (paralysed diaphragm) 
158093. Intraprocedural recurrent laryngeal nerve injury (palsy) 
158094. Postprocedural Horner’s syndrome 
158200. Postprocedural renal failure 
158206. Renal failure requiring temporary dialysis 
158207. Renal failure requiring permanent dialysis 
158221. Postprocedural gastrointestinal bleeding 
158223. Postprocedural inability to sustain gastric feeding 
158228. Postprocedural intestinal obstruction 
158229. Postprocedural peritonitis 
158230. Postprocedural necrotising enterocolitis 
158232. Pseudomembranous colitis 
158233. Postprocedural protein losing enteropathy 
158238. Postprocedural feeding difficulties 
158243. Postprocedural hepatic impairment 
158247. Postprocedural acute pancreatitis 
158250. Neurological complication after cardiac procedure 
158251. Postprocedural generalised seizures 
158253. Postprocedural temporary neurological impairment 
158257. Postprocedural permanent neurological impairment 
158264. Postprocedural brain death 
158266. Postprocedural cerebral abscess 
158267. Postprocedural new onset seizures 
158268. Postprocedural neurological impairment persisting at discharge 
158281. Postprocedural cerebral abnormality on imaging 
158800. Vascular line (access) related complication 
159001. Postprocedural complication 
159014. Procedure related complication 
159020. Complication during period of anaesthetic care 
165020. Complication following respiratory tract stent implantation 
101824. Postmyocardial infarction complication 
 
  
Data S2. Supplemental Results 
 
Summary of results from descriptive and univariate analyses 
 
Ethnic group was not available from PICANet for 1,703 children in the final dataset. Of these, the 
NCHDA ethnic code was used to assign white (n=1,001), Asian (n=243) or black (n=113). Excluding 
records without PICANet-derived ethnicity from the analyses did not significantly affect the results. A 
total of 528 children had missing or anomalous weight-for-age (assumed erroneous and treated as 
missing). The variable with the markedly highest level of missing data (n=2,101 (27.5%)) was 
prematurity (yes/no): sensitivity analysis comparing models with and without prematurity showed a 
marginally better fit if it was included and very little difference in the odds ratio coefficients for all 
other factors. 
 
The observed numbers of patients and rate of adverse events and fatal adverse events only for all 
candidate risk factors are shown below along with the results of the univariate analysis.  
 
The relationship between length of stay and both outcomes was non-linear and the fractional 
polynomial transformation was used in the subsequent risk model development analyses, whilst for 
age we used a log transformation. The relationship between weight-for-age and each outcome did not 
depart significantly from linearity. We used a multi-degree of freedom test for ethnicity, with results 
for fatal adverse events and all adverse events of p = 0.003 and p = 0.0001 respectively. 
 
 
Patient variable Num. (%) overall 
Fatal adverse events only All adverse events 
Num. (%) Univariate OR (p-value) Num. (%)  
Univariate 
OR (p-value) 
Non-medical      
Deprivation      
1 – most 2,205 (28.9) 79 (3.6) 1 157 (7.1) 1 
2 1,563 (20.5) 51 (3.3) 0.91 (0.60) 104 (6.7) 0.93 (0.58) 
3 1,242 (16.3) 41 (3.3) 0.92 (0.66) 77 (6.2) 0.86 (0.30) 
4 1,078 (14.1) 38 (3.5) 0.98 (0.93) 79 (7.3) 1.03 (0.83) 
5 – least 1,085 (14.2) 23 (2.1) 0.58 (0.02) 64 (5.9) 0.82 (0.19) 
Missing 470 (6.2) - - - - 
Ethnicity      
White 5,728 (75.0)  166 (2.9) 1 348 (6.1) 1 
Mixed 196 (2.6)  4 (2.0) 0.70 (0.48) 9 (4.6) 0.74 (0.39) 
Asian 867 (11.3)  38 (4.4) 1.54 (0.02) 73 (8.4) 1.42 (< 0.01) 
Black 345 (4.5)  12 (3.5) 1.21 (0.54) 34 (9.9) 1.69 (< 0.01) 
Chinese 28 (0.4)  3 (3.6) 1.24 (0.83) 1 (3.6) 0.57 (0.59) 
Other 133 (1.7)  12 (9.0) 3.32 (< 0.001) 19 (14.3) 2.58 (< 0.001) 
Not stated 346 (4.5) 13 (3.8) 1.31 (0.36) 30 (8.7) 1.47 (0.05) 
Pre-operative        
Cardiac diagnosis group      
VSD 1348 (17.6)  25 (1.9) 1 60 (4.5) 1 
HLHS 390 (5.1)  48 (12.3) 7.43 (< 0.001) 70 (18.0) 4.70 (< 0.001) 
UVH/PA 531 (7.0)  41 (7.7) 4.43 (< 0.001) 73 (13.8) 3.42 (< 0.001) 
Other 5374 (70.3)  132 (2.5) 1.33 (0.19) 311 (5.8) 1.32 (0.06) 
Acquired diagnosis      
Yes  479 (6.3) 25 (5.2) 1.73 (0.01) 57 (11.9) 1.98 (< 0.001) 
No 7164 (93.7) 221 (3.1) 1 457 (6.4) 1 
Specific procedure group      
Corrective  4973 (65.1)  86 (1.7) 1 219 (4.4) 1 
Palliative 1629 (21.3)  119 (7.3) 4.48 (< 0.001) 205 (12.6) 3.13 (< 0.001) 
Ungrouped 1041 (13.6)  41 (3.9) 2.33 (< 0.001) 90 (8.7) 2.05 (< 0.001) 
Congenital anomaly      
Yes 1608 (21.0)  90 (5.6) 2.23 (< 0.001) 209 (13.0) 2.81 (< 0.001) 
No 6035 (79.0)  156 (2.6) 1 305 (5.1) 1 
Neurodevelopment condition      
Yes 307 (4.0)  27 (8.8) 3.13 (< 0.001) 75 (24.4) 5.08 (< 0.001) 
No 7336 (96.0)  219 (3.0) 1 439 (6.0) 1 
Prematurity      
Yes 828 (10.8)  44 (5.3) 1.59 (< 0.01) 93 (11.2) 1.63 (< 0.001) 
No 4714 (61.7)  161 (3.4) 1 340 (7.2) 1 
Missing 2101 (27.5) - - - - 
Gender      
Male 4232 (55.4) 114 (3.4) 1 302 (7.1) 1 
Female 3410 (44.6) 102 (3.0) 0.88 (0.31) 212 (6.2) 0.86 (0.11) 
Not known 1 (0.0) - - - - 
Age at index procedure 
(continuous) 
 
Med. 64 days  
IQR (11,153) 
Missing = 0 
Not shown 0.99 (< 0.001) Not shown 0.99 (< 0.001) 
Weight-for-age Z-score 
(continuous) 
 
Med. -1.7 
IQR (-2.8,-0.6) 
Missing = 528 
Not shown 1.02 (0.69) * Not shown 0.95 (0.13) * 
Antenatal diagnosis      
Yes 2146 (8.1)  105 (4.9) 2.04 (< 0.001) 219 (10.2) 2.03 (< 0.001) 
No 5046 (66.0)  124 (2.5) 1 268 (5.3) 1 
Missing 451 (5.9) - - - - 
Clinical deterioration      
Yes 1469 (19.2)  85 (5.8) 2.29 (< 0.001) 154 (10.5) 1.89 (< 0.001) 
No 6174 (80.8)  161 (2.6) 1 36 (0.8) 1 
Post-operative      
Length of stay (continuous) 
Med. 10 days 
IQR (7, 17) 
Missing = 0 
Not shown (< 0.001) Not shown (< 0.001) 
Additional surgical procedures      
Yes 414 (5.4)  23 (5.6) 1.85 (< 0.01) 54 (13.0) 2.21 (< 0.001) 
No 7229 (94.6)  223 (3.1) 1 460 (6.4) 1 
Additional catheter procedures      
Yes 577 (7.6)  16 (2.8) 0.85 (0.53) 32 (5.6) 0.80 (0.24) 
No 7066 (92.4)  230 (3.3) 1 482 (6.8) 1 
Need for renal support      
Yes 522 (6.8)  31 (5.9) 1.99 (<0.01) 57 (10.9) 1.82 (< 0.001) 
No 6721 (87.9)  207 (3.1) 1 425 (6.3) 1 
Missing 400 (5.2) - - - - 
Need for ECMO      
Yes 64 (0.8)  5 (7.8) 2.53 (0.05) 9 (14.1) 2.32 (0.02) 
No 7290 (95.4)  236 (3.2) 1 480 (6.6) 1 
Missing 289 (3.8) - - - - 
Acquired comorbidity      
Yes 1481 (19.4)  84 (5.7) 2.19 (< 0.001) 165 (11.1) 2.15 (< 0.001) 
No 5918 (77.4)  158 (2.7) 1 326 (5.5) 1 
Missing 244 (3.2) - - - - 
Adverse event in PICU      
Yes 634 (8.3)  47 (7.4) 2.70 (< 0.001) 89 (14.0) 2.58 (< 0.001) 
No 6765 (88.5)  195 (2.9) 1 402 (5.9) 1 
Missing 244 (3.2) - - - - 
Post-op morbidity      
Yes 113 (1.5) 9 (8.0) 2.66 (< 0.01) 17 (15.0) 2.51 (< 0.01) 
No 7530 (98.5)  237 (3.2) 1 497 (6.6) 1 
 
PICU = paediatric intensive care unit; IQR = interquartile range; ECMO = extracorporeal membrane 
oxygenation; HLHS = hypoplastic left heart syndrome; UVH = functionally univentricular heart; PA 
= pulmonary atresia; VSD = Ventricular septal defect. 
* Weight-for-age z-score (continuous) showed no univariate association with either outcome but was 
nonetheless taken forward to the multivariable analyses. 
 
Details regarding the categorization of age at procedure, weight-for-age z-score and length of stay are 
presented below: these were initially continuous variables that were categorised due to considerations 
of potential model usability and clinical face validity. The observed numbers of patients and rate of 
fatal adverse events and all adverse events in the dataset in each category are shown for each 
categorized variable. 
 
 Num. (%) overall 
Num. (%) 
Fatal adverse 
events only 
Num. (%) All 
adverse events 
Age at index procedure    
> 3 months old 3202 (41.9) 55 (1.7) 129 (4.0) 
1-2 months old 1427 (18.7) 45 (3.2) 110 (7.7) 
10-30 days 1114 (14.6) 43 (3.9) 90 (8.1) 
0-10 days old 1900 (24.9) 103 (5.4) 185 (9.7) 
Weight-for-age z-score    
>-2SD 4064 (53.2) 128 (3.1) 243 (6.0) 
-2 to -4 SD 2467 (32.3) 71 (2.9) 168 (6.8) 
<-4SD 584 (7.6) 19 (3.3) 50 (8.6) 
Missing 528 (6.9) 28 (5.3) 53 (10.0) 
Length of stay    
0-7 days 2564 (33.5) 35 (1.4) 84 (3.3) 
7-30 days 4327 (56.6) 146 (3.4) 302 (7.0) 
> 1 month 752 (9.8) 65 (8.6) 128 (17.0) 
 
Multiple imputation results 
 
For both outcomes there was very little difference in the significance of risk factors between the 
imputed data sets; there was a clear set of significant factors (p < 0.01) with an inclusion frequency of 
100% and a clear set of factors that did not reach statistical significance with an inclusion frequency 
of 0%. For fatal adverse events only there were two factors (prematurity and acquired diagnosis) and 
for all adverse events three factors (prematurity, antenatal diagnosis and clinical deterioration) that 
were borderline significant, with an inclusion frequency of approximately 50%. These borderline risk 
factors were investigated further along with the set of significant risk factors and only prematurity 
remained statistically significant. The Multiple Imputation suite of programs in Stata was used to 
conduct the imputation analysis. 
 
Continuous logistic regression models 
Details of the continuous regression model for fatal adverse events only (death within 1-year 
following discharge from the index admission and not during a planned admission) are shown below. 
For each patient variable the number (percentage) of fatal adverse events, multivariable odds ratios, 
standard errors and 95% confidence intervals are presented and the reference category indicated. The 
overall number (percentage) of patients within each category for a given patient variable is also noted. 
HLHS = hypoplastic left heart syndrome; UVH = functionally univentricular heart; PA+IVS = 
pulmonary atresia with an intact ventricular septum; VSD = ventricular septal defect. 
† Log transformation ‡Fractional polynomial transformation. 
 
 
Patient variable Overall number (%) 
Number (%) fatal 
adverse events OR S.E. 95% CI 
Ethnicity       
White 5,728 (75.0) 166 (2.9) Reference category 
Mixed 196 (2.6) 4 (2.0) 0.69 0.36 0.25 1.91 
Asian 867 (11.3) 38 (4.4) 1.38 0.26 0.95 2.01 
Black 345 (4.5) 12 (3.5) 0.98 0.31 0.53 1.83 
Chinese 28 (0.4) 3 (3.6) 1.61 1.68 0.21 12.46 
Other 133 (1.7) 12 (9.0) 2.97 0.99 1.54 5.73 
Not stated 346 (4.5) 13 (3.8) 1.49 0.46 0.82 2.71 
Cardiac diagnosis group       
VSD 1348 (17.6) 25 (1.9) Reference category 
HLHS 390 (5.1) 48 (12.3) 2.70 0.86 1.45 5.04 
UVH or PA+IVS 531 (7.0) 41 (7.7) 2.29 0.68 1.28 4.11 
Other 5374 (70.3) 132 (2.5) 1.14 0.27 0.72 1.80 
Specific procedure group       
Corrective  4973 (65.1) 86 (1.7) Reference category 
Palliative 1629 (21.3) 119 (7.3) 2.15 0.39 1.51 3.06 
Ungrouped 1041 (13.6) 41 (3.9) 1.78 0.36 1.20 2.64 
Congenital anomaly       
No 6035 (79.0) 156 (2.6) Reference category 
Yes 1608 (21.0) 90 (5.6) 2.29 0.35 1.70 3.09 
Prematurity       
No 4714 (61.7) 161 (3.4) Reference category 
Yes 828 (10.8) 44 (5.3) 1.55 0.28 1.09 2.20 
Clinical deterioration       
No 6174 (80.8) 161 (2.6) Reference category 
Yes 1469 (19.2) 85 (5.8) 1.59 0.23 1.19 2.12 
Age at index procedure†       
 - - 0.77 0.05 0.68 0.87 
Weight-for-age z-score       
 - - 0.83 0.05 0.74 0.92 
Index length of stay‡       
First degree of polynomial - - 3239 4361 231 45332 
Second degree of 
polynomial - - 
0.00 0.00 0.00 0.00 
 
 
 
 
 
 
 
 
 
Details of the continuous regression model for all adverse events (either death or an emergency 
unplanned readmission to PICU within 1-year following discharge from the index admission) are 
shown below. For each patient variable the number (percentage) of adverse events, the multivariable 
odds ratios, standard errors and 95% confidence intervals are presented and the reference category 
indicated. The overall number (percentage) of patients within each category for a given patient 
variable is also noted. 
HLHS = hypoplastic left heart syndrome; UVH = functionally univentricular heart; PA+IVS = 
pulmonary atresia with an intact ventricular septum; VSD = ventricular septal defect. 
† Log transformation ‡Fractional polynomial transformation. 
 
Patient variable 
Overall 
number 
(%) 
Number (%)  
adverse events OR S.E. 95% CI 
Ethnicity       
White 5,728 (75.0) 348 (6.1) Reference category 
Mixed 196 (2.6) 9 (4.6) 0.64 0.23 0.32 1.31 
Asian 867 (11.3) 73 (8.4) 1.22 0.18 0.92 1.62 
Black 345 (4.5) 34 (9.9) 1.40 0.29 0.94 2.09 
Chinese 28 (0.4) 1 (3.6) 0.70 0.72 0.09 5.32 
Other 133 (1.7) 19 (14.3) 2.52 0.68 1.48 4.29 
Not stated 346 (4.5) 30 (8.7) 1.71 0.36 1.13 2.58 
Cardiac diagnosis group       
VSD 1348 (17.6) 60 (4.5) Reference category 
HLHS 390 (5.1) 70 (18.0) 2.08 0.49 1.31 3.30 
UVH or PA+IVS 531 (7.0) 73 (13.8) 2.06 0.44 1.35 3.14 
Other 5374 (70.3) 311 (5.8) 1.18 0.19 0.87 1.61 
Specific procedure group       
Corrective 4973 (65.1) 219 (4.4) Reference category 
Palliative 1629 (21.3) 205 (12.6) 1.72 0.22 1.34 2.22 
Ungrouped 1041 (13.6) 90 (8.7) 1.62 0.22 1.24 2.13 
Congenital anomaly       
No 6035 (79.0) 305 (5.1) Reference category 
Yes 1608 (21.0) 209 (13.0) 2.62 0.28 2.12 3.24 
Neurodevelopment condition       
No 7336 (96.0) 439 (6.0) Reference category 
Yes 307 (4.0) 75 (24.4) 2.71 0.43 1.99 3.69 
Prematurity       
No 4714 (61.7) 340 (7.2) Reference category 
Yes 828 (10.8) 93 (11.2) 1.50 0.20 1.15 1.95 
Acquired diagnosis       
No 7164 (93.7) 457 (6.4) Reference category 
Yes 479 (6.3) 57 (11.9) 1.76 0.28 1.28 2.41 
Age at index procedure†       
 - - 0.77 0.03 0.70 0.83 
Weight-for-age z-score       
 - - 0.83 0.03 0.77 0.90 
Index length of stay‡       
First degree of polynomial - - 2254 2151 347 14633 
Second degree of polynomial - - 0.00 0.00 0.00 0.00 
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